AP2M1 and colorectal carcinoma: It has been recently shown that AP2M1 participates in the transmission of soluble signals from senescent CRC cells to promote resistance to chemotherapy (Le Duff et al., 2018), suggesting that AP2M1 upregulation by DNA hypomethylation could be a novel mechanism by which CTCs escape from chemotherapy.